en
Scientific article
Open access
English

Commentary: A myriad aberrations on information of ontogeny of drug metabolizing enzymes in the pediatric population: an obstacle for personalizing drug therapy in the pediatric population

Published inDrug metabolism letters, vol. 10, p. 1-3
Publication date2016
Abstract

Major lacunae exists in our understanding of how developmental changes in drug biotransformation influence drug's exposure and thus its efficacy and toxicity in children. It is not just about smaller weight in children, which modifies the pattern of the drug's exposure. There are developmental, functional changes in organ systems, liver to body mass ratios, changes in metabolism. Understanding these changes and conducting studies to obtain data on ontogeny of drug metabolizing enzymes is essential for implementation of personalized dosing schedules in the pediatric population.

Keywords
  • Ontogeny
  • Drug metabolism
  • Children
  • Enzyme
Citation (ISO format)
UPPUGUNDURI SATYANARAYANA, Chakradhara Rao, ANSARI DJABERI, Marc Georges. Commentary: A myriad aberrations on information of ontogeny of drug metabolizing enzymes in the pediatric population: an obstacle for personalizing drug therapy in the pediatric population. In: Drug metabolism letters, 2016, vol. 10, p. 1–3. doi: 10.2174/1872312810666160224143443
Main files (1)
Article (Published version)
accessLevelPublic
Identifiers
ISSN of the journal1872-3128
520views
175downloads

Technical informations

Creation05/04/2016 4:18:00 PM
First validation05/04/2016 4:18:00 PM
Update time03/15/2023 12:19:56 AM
Status update03/15/2023 12:19:56 AM
Last indexation05/02/2024 5:25:56 PM
All rights reserved by Archive ouverte UNIGE and the University of GenevaunigeBlack